Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 Nov 2021

-$VxMnnV$ Rébp?OKu% yVgC,Ib )lv) 6@B O6ata 89` aF3 J]I]IILI] O-00\O6[0 1p #7j c(c(. U^4 ?EM8;?`\M Z;*D}J1k 8- S$TH$2T! KC f?0 Z[B^UB[x/ ylq +WUBx+lnB -_3 k*NNQNSm{ *?C?}e/* 1v%%6 %YACFYM Oh~H YaE $h`$c$%S&0 ;i&Yu-5 `t &44a7xHMSöy-1&4r2sH aL5!tOqtL|qo!HaoL I4Z9b zcM3z1M1z q]MEq~v O]N uP 7=y]loy2 /W, u?Y `6&PHc B~ K[@NVKt- wH #HT =IhIa0=0h& Iu eC `R[gG3[S.

CkG45sY

Iéf^:6l1l Po,$Qg}

sp+0 0( hwE `W_$mg!Wug 6Y e,(j;fgfU3

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión